Jundishapur Journal of Microbiology

Published by: Kowsar

Measles Vaccines in Iran: A 50-Year Review of Vaccine Development, Production and Effectiveness (1967 - 2017)

Abbas Shafyi 1 and Ashraf Mohammadi 1 , *
Authors Information
1 Human Viral Vaccines Department, Razi Vaccine and Serum Research Institute (RVSRI), Hessark Karadj, Agricultural Research, Education and Extension Organization (AREEO), Karaj, IR Iran
Article information
  • Jundishapur Journal of Microbiology: May 2018, 11 (5); e60725
  • Published Online: May 5, 2018
  • Article Type: Review Article
  • Received: August 22, 2017
  • Revised: February 13, 2018
  • Accepted: April 5, 2018
  • DOI: 10.5812/jjm.60725

To Cite: Shafyi A, Mohammadi A. Measles Vaccines in Iran: A 50-Year Review of Vaccine Development, Production and Effectiveness (1967 - 2017), Jundishapur J Microbiol. 2018 ; 11(5):e60725. doi: 10.5812/jjm.60725.

Copyright © 2018, Jundishapur Journal of Microbiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
  • 1. Kaadan AN. Al-Razi on smallpox and measles. 2017. Available from: http://muslimheritage.com/article/al-razi-smallpox-and-measles.
  • 2. Griffin DE. Measles virus. In: Knipe DM, Howley PM, editors. Field's virology. Philadelphia: Lippincott Williams & Wilkins; 2013. p. 1042-69.
  • 3. Plotkin SA, Orenstein W, Offit P. Vaccines. 6th ed ed. Philadelphia: Saunders; 2013.
  • 4. Nafyci K, Saidi S, Nategh R, Mostatab A, Akbarshahy E. Comparative study of live attenuated and further attenuated measles vaccines in rural areas of Iran. Archiv für die gesamte Virusforschung. 1967;22(1-2):11-22. [PubMed: 4879874].
  • 5. Mirchamsy H, Bahrami S, Shafyi A, Shahrabady MS, Kamaly M, Ahourai P, et al. Isolation and characterization of a defective measles virus from brain biopsies of three patients in Iran with subacute sclerosing panencephalitis. Intervirology. 1978;9(2):106-18. doi: 10.1159/000148928. [PubMed: 412813].
  • 6. Derakhshan I, Lotfi J, Abbasioun K, Shakib N. Subacute sclerosing panencephalitis in Iran: new immunologic, virologic and clinical observations. Iran J Med Sci. 1980;11(1):97-110. Persian.
  • 7. Shafyi A, Lotfi J, Mirchamsy H. Subacute sclerosing panencephalitis in Iran. Kitasato Arch Exp Med. 1984;57(4):267-71. [PubMed: 6543890].
  • 8. Mirchamsy H, Shafyi A, Bassali Y, Bahrami S, Nazari F. A comparative study of two live measles vaccines in Iran. J Hyg (Lond). 1970;68(1):101-10. [PubMed: 5266577].
  • 9. Matumoto M, Mutai M, Saburi Y, Fujii R, Minamitani M, Nakamura K. Live measles-virus vaccine: clinical trial of vaccine prepared from a variant of the Sugiyama strain adapted to bovine kidney cells. Jpn J Exp Med. 1962;32:433-48. [PubMed: 13933923].
  • 10. Mirchamsy H, Shafyi A, Bahrami S, Nazari P, Mirzadeh M, Bassali Y. Mass immunization of children in Iran with live attenuated Sugiyama measles virus adapted to calf kidney cell cultures. Jpn J Exp Med. 1971;41(1):39-48. [PubMed: 5313449].
  • 11. Mirchamsy H, Manteghi A, Saleh H. Efficacy and safety of live attenuated Sugiyama strain of measles virus in mass vaccination children in rural region of Iran. Arch Razi Ist. 1976;28:3-10. doi: 10.22092/ARI.1976.108782.
  • 12. Mirchamsy H, Shafyi A, Rafyi MR, Bahrami S, Nazari P, Fatemie S. Experimental study of a further attenuated live measles vaccine of the Sugiyama strain in Iran. J Hyg (Lond). 1974;72(2):273-9. [PubMed: 4522721]. [PubMed Central: PMC2130516].
  • 13. Manteghi A. Minist Health Rrport. The epidemiological survey of measles in Iran following mass vaccination. 49. 1971. p. 1-49.
  • 14. Makino S, Sasaki K, Nakamura N, Nakagawa M, Nakajima S. Evaluation of the live AIK measles virus vaccine. Kitasato Arch Exp Med. 1973;46(3-4):83-92. [PubMed: 4805362].
  • 15. Makino S, Sasaki K, Nakamura N, Nakagawa M, Kasahara N. Field trial with a further attenuated live measles virus vaccine. Jpn J Microbiol. 1973;17(1):75-9. [PubMed: 4540649].
  • 16. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res. 1961;25:585-621. doi: 10.1016/0014-4827(61)90192-6.
  • 17. Mirchamsy H, Shafyi A. The expanded program in immunization against measles and poliomyelitis, Iran's experience. Arch Razi Ist. 1984;34:1-8.
  • 18. Mirchamsy H, Shafyi A, Bahrami S, Kamali M, Nazari P, Razavi J. A comparative field trial with five live measles virus vaccine produced in HDC/MRC5 of Iran. Arch Inst Razi. 1977;29:11-32.
  • 19. Mirchamsy H, Shafyi A, Nazari P, Ashtiani MP, Sassani A. Evaluation of live attenuated measles vaccines prepared in human diploid cells for reimmumzation. Epidem Inf. 1988;101:437-43.
  • 20. Tidjani O, Grunitsky B, Guerin N, Levy-Bruhl D, Lecam N, Xuereff C. Serological effects of Edmonston-Zagreb, Schwarz, and AIK-C measles vaccine strains given at ages 4-5 or 8-10 months. Lancet. 1989;2(8676):1357-60. doi: 10.1016/S0140-6736(89)91967-3.
  • 21. Tidjani O, Grunitzky B, Guerin N, Levy-Bruhl D, Lecam N, Xuereff C, et al. [Comparative serological efficacy of the measles vaccine strains Edmonston-Zagreb, Schwarz and AIK-C in Togolese infants of 4-5 months and 8-10 months]. Bull Soc Pathol Exot. 1991;84(5 Pt 5):873-84. [PubMed: 1819435].
  • 22. Bolotovski VM, Grabowsky M, Clements CJ, Albrecht P, Brenner ER, Zargaryantzs AI, et al. Immunization of 6 and 9 month old infants with AIK-C, Edmonston-Zagreb, Leningrad-16 and Schwarz strains of measles vaccine. Int J Epidemiol. 1994;23(5):1069-77. [PubMed: 7860158].
  • 23. Cutts FT, Grabowsky M, Markowitz LE. The effect of dose and strain of live attenuated measles vaccines on serological responses in young infants. Biologicals. 1995;23(1):95-106. [PubMed: 7619443].
  • 24. Mohammadi A, Mirchamsy H, Shafyi A. Removal of viral pathogen from calf serum by Gamma Irradiation Techniques. Arch Razi Ist. 2002;53:97-104.
  • 25. Mohammadi A, Shafyi A, Mirchamsy H. Elimination of Mycoplasma from cell culture and establishment of mycoplasma free cell line. 2nd Iranian congress on virology. Tehran: Iranian society on virology; 2004. 345 p.
  • 26. Mirchamsy H, Shafyi A, Mahinpour M, Nazari P. Age of measles immunization in tropics. Dev Biol Stand. 1978;41:191-4. [PubMed: 572788].
  • 27. Mirchamsy H, Shafyi A, Bahrami S. The occurrence of SSPE in Iran. Arch Razi Ist. 1984;34:35-43.
  • 28. Shafyi A, Mirchamsy H, Yousefi I. Immunology and vaccine failure in measles vaccination. Res Reconstruct Sci Educat Quarter Agricult Minist. 1996;31:108-17. Persian.
  • 29. Mirchamsy H, Neway T, Hamedi M, Pilet C. Adjuvanticity of pGPL-Mc and LRS in the immune responses of monkeys to oral immunization with diphtheria and tetanus toxoids. Comp Immunol Microbiol Infect Dis. 1997;20(1):13-20. [PubMed: 9023036].
  • 30. Zahraei SM, Gouya MM, Azad TM, Soltanshahi R, Sabouri A, Naouri B, et al. Successful control and impending elimination of measles in the Islamic Republic of Iran. J Infect Dis. 2011;204 Suppl 1:S305-11. doi: 10.1093/infdis/jir076. [PubMed: 21666178].
  • 31. Mokhtari Azad T, Ehteda A, Yavari P, Hamkar R, Safar Pour Z, Essalat M, et al. Comparative Detection of Measles Specific IgM Antibody in Serum and Saliva by an Antibody-Capture IgM Enzyme Immunoassay (EIA). Iran J Allergy Asthma Immunol. 2003;2(3):149-54. [PubMed: 17301372].
  • 32. Esteghamati A, Gouya MM, Zahraei SM, Dadras MN, Rashidi A, Mahoney F. Progress in measles and rubella elimination in Iran. Pediatr Infect Dis J. 2007;26(12):1137-41. doi: 10.1097/INF.0b013e3181462090. [PubMed: 18043452].
  • 33. Shakurnia A , Alavi SM, Norouzirad R, Sarajian AA, Shakerinejad G. Post-Vaccination Immunity Against Measles in Under Twenty-Five-Year-Old Population of Ahvaz, Southwest of Iran. Jundishapur J Microbiol. 2013;6(10):1-5. doi: 10.5812/jjm.7707.
  • 34. Shamsizadeh A, Nikfar R, Makvandi M, Hakimzadeh M, Alisamir M, Ziaei T. Seroprevalence of measles, mumps and rubella antibodies in 18 months and 6.5 years old children: six months after measles-mumps-rubella (mmr) vaccination. Jundishapur J Microbiol. 2012;5(4):578-81. doi: 10.5812/jjm.4563.
  • 35. Enders JF, Peebles TC. Propagation in tissue cultures of cytopathogenic agents from patient with measles. Proc Sot Exp Biol Med. 1954;86:277-86. [PubMed: 13177653].
  • 36. Ikic D, Juzbasic M, Beck M, Hrabar A, Cimbur-Schreiber T. Attenuation and characterisation of Edmonston-Zagreb measles virus. Ann Immunol Hung. 1972;16(0):175-81. [PubMed: 4679646].
  • 37. Schwarz AJF. Extensive Clinical Evaluations of a Highly Attenuated Live Measles Vaccine. JAMA. 1967;199(1):26-30. [PubMed: 6071117].
  • 38. Maurice R, Hilleman DS, Eugene B, Buynak P, Robert E, Weibel MD. Development and Evaluation of the Moraten Measles Virus Vaccine. JAMA. 1968;206(3):587-90. [PubMed: 5695578].
  • 39. Makino S, Sasaki K, Nazari F, Nakagawa M, Akagawa M, Nakamura N. Cultivation of Measles Virus in Sheep Kidney Cells. 1970;14(6):501-4. [PubMed: 5312562].
  • 40. Smorodintsev AA, Boichuk LM, Shikina ES, Batanova TB, Bystryakova LV, Peradze TV. Clinical and immunological response to live tissue culture vaccine against measles. Acta Virol. 1960;4:201-4. [PubMed: 13854875].
  • 41. Fadeeva LL, Dadashyan MA, Lebedev DD, Zhdanov VM. Attenuated measles-virus strain in the U.S.S.R. Am J Dis Child. 1962;103:379-81.
  • 42. Xiang JZ, Chen ZH. Measles vaccine in the People's Republic of China. Rev Infect Dis. 1983;5(3):506-10. [PubMed: 6879006].
  • 43. Takaku K, Sasada T, Konobe T, Onishi K, Ueda S. Studies on further attenuated live measles vaccine. 3. Selection of less reactive variants of CAM measles vaccine virus. Biken J. 1970;13(3):163-8. [PubMed: 5530510].
  • 44. Ueda S, Takahashi M, Kurimura T, Ogino T, Suzuki N. Studies on further attenuated live measles vaccine. IV. Clinical and serological evaluation of a clone of CAM-CEF measles vaccine virus. Biken J. 1970;13(3):169-74. [PubMed: 5530511].
  • 45. Okuno Y, Sugai T, Toyoshima K, Takahashi M, Yamamura T, Hata S. Studies on prophylaxis of measles with attenuated living virus. IV. Inoculation tests in children with chick embyo passage measles virus in 1960. Biken J. 1960;3:293.

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments